BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 7, 1999
View Archived Issues
Pravastatin activates eNOS, provides additional clinical benefits
Read More
Variagenics granted exclusive license for genetic marker of cardiovascular disease
Read More
Licensing opportunity from Yeda: iron chelators for treatment of neurologic disorders
Read More
Ligand and Ferrer enter marketing agreement for five Ligand products
Read More
ProScript receives SBIR grant for novel stroke treatment
Read More
AutoImmune and Lilly to restructure collaborative agreement for diabetes treatment
Read More
Schering-Plough seeks further E.U. approval for Temodal
Read More
FDA approves ANDA for Oruvail
Read More
New carbapenems synthesized at Merck useful against resistant staphylococci
Read More
Meiji Milk presents new therapeutics for dementia that stimulate neurite growth
Read More
Sanofi's new CRF antagonists: preparation, use and pharmaceutical compositions
Read More
PhotoVision in-licenses novel technology for development of AMD treatment
Read More
Growth factor receptor PTK inhibitors in development by American Cyanamid
Read More
Pfizer discloses new series of bradykinin antagonists
Read More
Glycine-site NMDA antagonist is safe and well tolerated in stroke patients
Read More
Selective NMDA antagonists in the Lilly pipeline
Read More
Novartis identifies thrombin inhibitors with improved pharmacodynamic and pharmacokinetic properties
Read More
Abgenix and BASF to collaborate on antibody development
Read More
Organon designs and synthesizes orally active thrombin inhibitors based on NAPAP
Read More
Novel antibiotic active against acid-fast bacteria presented at recent Japanese congress
Read More
LBP199-IgG1 Fc: a new endotoxin-neutralizing fusion protein
Read More
Identification and neuroprotective activity of GV-224029 discussed at ACS meeting
Read More
Roche, deCode Genetics close in on osteoarthritis disease-causing gene
Read More
Small-molecule N-type Ca2+ channel blockers designed by Neurex/Parke-Davis group
Read More
A new fluoroquinolone derivative effective against HIV-1
Read More
Merger of Astra and Zeneca now officially completed
Read More
Phytopharm assumes increased responsibility for development of unique botanical product
Read More
New orally active NEP inhibitor exerts beneficial effects in rabbit model of CHF
Read More